About
Sheraz Ali is a Research Fellow at Bond University's Faculty of Health Sciences & Medicine, affiliated with the Institute for Evidence-Based Healthcare. His work focuses on antibiotic resistance, antimicrobial stewardship, and implementation science, particularly in primary care settings. He leads a world-first trial aiming to reduce inappropriate antibiotic use through multidisciplinary collaboration.
Education:
- PhD (Assessing Medicines-related Harm in Australian Aged Care Residents), University of Tasmania (2024)
- Masters in Public Health, University of Eastern Finland (2014)
- PharmD, Baqai Medical University (2011)
Research Interests: Sheraz’s research addresses global public health challenges, including optimizing antibiotic prescribing, medication safety, and evidence synthesis. His work aligns with UN Sustainable Development Goals, particularly in advancing healthcare quality and reducing preventable harm. Recent studies focus on adverse drug events in Saudi Arabia and Australia, patient-centered care in neurology and psychiatry, and healthcare service satisfaction.
Advising & Grants: While no advisees are listed, his current projects involve collaborations with consumers, community partners, and multidisciplinary teams to implement evidence-based practices. He has contributed to over 39 research outputs since 2014, including trials and systematic reviews.
Labs/Teams: Part of the Institute for Evidence-Based Healthcare, he engages in cross-border research collaborations, with recent partnerships in Saudi Arabia, Australia, and Finland.
